KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $28,453,000 | +11.4% | 1,930,322 | 0.0% | 0.62% | +38.0% |
| Q4 2021 | $25,538,000 | -24.2% | 1,930,322 | 0.0% | 0.45% | -3.6% |
| Q3 2021 | $33,684,000 | -27.2% | 1,930,322 | 0.0% | 0.47% | -37.1% |
| Q2 2021 | $46,251,000 | +414.4% | 1,930,322 | +451.5% | 0.74% | +445.6% |
| Q1 2021 | $8,992,000 | -78.2% | 350,000 | -75.7% | 0.14% | -92.4% |
| Q1 2019 | $41,243,000 | +44.9% | 1,441,070 | 0.0% | 1.78% | +7.3% |
| Q4 2018 | $28,461,000 | -10.7% | 1,441,070 | 0.0% | 1.66% | -2.7% |
| Q3 2018 | $31,862,000 | +172.3% | 1,441,070 | 0.0% | 1.70% | +124.1% |
| Q2 2018 | $11,701,000 | -14.3% | 1,441,070 | 0.0% | 0.76% | -27.4% |
| Q1 2018 | $13,661,000 | -2.8% | 1,441,070 | 0.0% | 1.05% | -11.0% |
| Q4 2017 | $14,050,000 | +223.0% | 1,441,070 | +143.8% | 1.18% | +199.2% |
| Q3 2017 | $4,350,000 | 0.0% | 591,070 | 0.0% | 0.39% | -21.2% |
| Q2 2017 | $4,350,000 | -5.8% | 591,070 | 0.0% | 0.50% | -11.8% |
| Q1 2017 | $4,616,000 | +10.5% | 591,070 | 0.0% | 0.57% | -4.4% |
| Q4 2016 | $4,179,000 | – | 591,070 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |